TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 14715393

Group type: EXPERIMENTAL
Intervention: Aspirin 600/650 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Paracetamol 600/650 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Paracetamol 1000 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ibuprofen 400 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 11887670

Group type: EXPERIMENTAL
Intervention: Dental appliance treatment for headache patients
Number of subjects: 0
Study: 9597297

Group type: EXPERIMENTAL
Intervention: Failure to imbibe
Number of subjects: 128

Group type: COMPARATOR
Intervention: Nonorganic failure to thrive
Number of subjects: 128

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 128

Group type: COMPARATOR
Intervention: Diseased controls
Number of subjects: 128
Study: 7870637

Group type: EXPERIMENTAL
Intervention: Low-energy, fruit- and vegetable-enriched prudent diet (Group A)
Number of subjects: 406

Group type: COMPARATOR
Intervention: Control group (Group B)
Number of subjects: 406
Study: 3170120

Group type: EXPERIMENTAL
Intervention: Timolol maleate
Number of subjects: 46

Group type: COMPARATOR
Intervention: Untreated (control)
Number of subjects: 46
Study: 30936104

Group type: EXPERIMENTAL
Intervention: Ceftriaxone (1g/24hrs)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Cefotaxime (1g/8hrs)
Number of subjects: 22
Study: 28427955

Group type: EXPERIMENTAL
Intervention: CHOICES Plus
Number of subjects: 261

Group type: COMPARATOR
Intervention: Brief Advice
Number of subjects: 261
Study: 25261004

Group type: EXPERIMENTAL
Intervention: Point-of-care (POC) cardiac troponin-T testing
Number of subjects: 452

Group type: COMPARATOR
Intervention: Laboratory-based cardiac troponin-T testing
Number of subjects: 452
Study: 23858436

Group type: EXPERIMENTAL
Intervention: Condition C (4-year-old child)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Condition A (adult body)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Visuomotor asynchrony (Exp. 2)
Number of subjects: 30
Study: 20643762

Group type: EXPERIMENTAL
Intervention: Oral cyclophosphamide (CYC)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Infliximab combined with oral CYC
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Other agents including biological agents
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Induction-refractory disease characteristics
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Induction-refractory disease mortality
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Massive alveolar haemorrhage
Number of subjects: 32
Study: 18419216

Group type: EXPERIMENTAL
Intervention: High-energy transurethral microwave thermotherapy (HE-TUMT) with CoreTherm device
Number of subjects: 458

Group type: COMPARATOR
Intervention: Transurethral resection of the prostate (TURP)
Number of subjects: 458
Study: 15937580

Group type: EXPERIMENTAL
Intervention: Middle Eastern women with PCOS
Number of subjects: 92

Group type: COMPARATOR
Intervention: Western European women with PCOS
Number of subjects: 92
Study: 12946761

Group type: EXPERIMENTAL
Intervention: Intracorporeal injection
Number of subjects: 1023

Group type: EXPERIMENTAL
Intervention: Peak systolic velocity
Number of subjects: 1023

Group type: EXPERIMENTAL
Intervention: Rigidometer values
Number of subjects: 1023

Group type: EXPERIMENTAL
Intervention: End-diastolic velocity
Number of subjects: 1023

Group type: EXPERIMENTAL
Intervention: Resistive index
Number of subjects: 1023

Group type: EXPERIMENTAL
Intervention: Duration of diabetes, control of diabetes, diabetes-related complications
Number of subjects: 1023
Study: 10955702

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: L-NAME
Number of subjects: 8
Study: 8899091

Group type: EXPERIMENTAL
Intervention: Low-dose rINF-beta ser (6 x 10(6) U/dose, three times a week for 6 months)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: High-dose rINF-beta ser (30 x 10(6) U/dose, three times a week for 6 months)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both low-dose and high-dose rINF-beta ser
Number of subjects: 20
Study: 1999536

Group type: EXPERIMENTAL
Intervention: Cultured skin equivalents
Number of subjects: 5

Group type: COMPARATOR
Intervention: Full-thickness skin punch grafts
Number of subjects: 5
Study: 6190489

Group type: EXPERIMENTAL
Intervention: Vecuronium
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Atracurium
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Duador
Number of subjects: 50
Study: 31945691

Group type: EXPERIMENTAL
Intervention: Bilateral bone conduction devices (BCDs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Unilateral bone conduction devices (BCDs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Unilateral bone conduction devices (BCDs) in simulated bilateral conductive hearing loss
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal open ear (control)
Number of subjects: 0
Study: 31324402

Group type: EXPERIMENTAL
Intervention: Organic produce
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional produce
Number of subjects: 20
Study: 30431588

Group type: EXPERIMENTAL
Intervention: Rituximab (RTX)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (standard treatment)
Number of subjects: 61
Study: 27126292

Group type: EXPERIMENTAL
Intervention: Head Excursion Test (HET)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Trunk Excursion Test (TET)
Number of subjects: 100
Study: 25148243

Group type: EXPERIMENTAL
Intervention: Atomoxetine (20-50 mg BID)
Number of subjects: 445

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 445
Study: 21913966

Group type: EXPERIMENTAL
Intervention: Intensive multifactorial cardiovascular risk intervention
Number of subjects: 345

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 345
Study: 20225658

Group type: EXPERIMENTAL
Intervention: Genistein
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Puerarin
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control
Number of subjects: 32
Study: 17106430

Group type: EXPERIMENTAL
Intervention: Transiently evoked otoacoustic emissions
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (40 age-matched healthy volunteers)
Number of subjects: 24
Study: 15696445

Group type: EXPERIMENTAL
Intervention: Chronic kidney disease (CKD) categorized by estimated Glomerular Filtration Rate (eGFR)
Number of subjects: 1015

Group type: EXPERIMENTAL
Intervention: eGFR
Number of subjects: 1015
Study: 12425155

Group type: EXPERIMENTAL
Intervention: Laparoscopic appendectomy (LA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Open appendectomy (OA)
Number of subjects: 0
Study: 10588630

Group type: EXPERIMENTAL
Intervention: Synchronized CXR using the interface
Number of subjects: 25

Group type: COMPARATOR
Intervention: Conventional CXR techniques
Number of subjects: 25
Study: 7598919

Group type: EXPERIMENTAL
Intervention: Central venous monitoring
Number of subjects: 104

Group type: COMPARATOR
Intervention: No central venous monitoring
Number of subjects: 104
Study: 2180557

Group type: EXPERIMENTAL
Intervention: Allopurinol mouthwash (20 mg)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo mouthwash
Number of subjects: 77
Study: 7462462

Group type: EXPERIMENTAL
Intervention: Isolated vowels
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vowels in consonantal context
Number of subjects: 0
Study: 31888605

Group type: EXPERIMENTAL
Intervention: Understanding low back pain booklet
Number of subjects: 136
Study: 28682100

Group type: EXPERIMENTAL
Intervention: Relevance interventions (specific types not detailed)
Number of subjects: 1916

Group type: COMPARATOR
Intervention: Control group (specific details not provided)
Number of subjects: 1916
Study: 26060991

Group type: EXPERIMENTAL
Intervention: Text messaging interviews (administered by human interviewers)
Number of subjects: 634

Group type: EXPERIMENTAL
Intervention: Text messaging interviews (administered by automated systems)
Number of subjects: 634

Group type: COMPARATOR
Intervention: Voice interviews (administered by human interviewers)
Number of subjects: 634

Group type: COMPARATOR
Intervention: Voice interviews (administered by automated systems)
Number of subjects: 634

Group type: EXPERIMENTAL
Intervention: Text messaging interviews (both human and automated)
Number of subjects: 634

Group type: EXPERIMENTAL
Intervention: Text messaging interviews
Number of subjects: 634
Study: 23503829

Group type: EXPERIMENTAL
Intervention: Digital stethoscope (Littmann® Model 3200, 3M)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Conventional stethoscopes
Number of subjects: 38
Study: 21682627

Group type: EXPERIMENTAL
Intervention: Poetry writing workshop
Number of subjects: 28

Group type: COMPARATOR
Intervention: Wait-listed group (control)
Number of subjects: 28
Study: 19111849

Group type: EXPERIMENTAL
Intervention: IM aripiprazole 10 mg
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: IM aripiprazole 15 mg
Number of subjects: 129

Group type: COMPARATOR
Intervention: IM placebo
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: IM aripiprazole (5 mg, 10 mg, or 15 mg)
Number of subjects: 129
Study: 17014022

Group type: EXPERIMENTAL
Intervention: Combination therapy (amitriptyline and fluoxetine)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 58
Study: 15150721

Group type: EXPERIMENTAL
Intervention: Psychometric measures of body plasticity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Somatic preoccupation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Creative imagination
Number of subjects: 0
Study: 11090839

Group type: COMPARATOR
Intervention: Ischemic preconditioning (PC)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: CT-1 (1 nM)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Ischemic preconditioning (PC) on day 1
Number of subjects: 6

Group type: COMPARATOR
Intervention: Ischemic preconditioning (PC) on day 2
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: CT-1 for 24 h before 30 min ischemia
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: CT-1 for 24 h before 90 min ischemia
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: CT-1 antibody
Number of subjects: 6

Group type: COMPARATOR
Intervention: Ischemic preconditioning (PC) with CT-1 antibody
Number of subjects: 6
Study: 9281254

Group type: EXPERIMENTAL
Intervention: CMF-chemotherapy
Number of subjects: 17
Study: 8193733

Group type: EXPERIMENTAL
Intervention: Isradipine, 2.5 mg twice daily
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 3946761

Group type: EXPERIMENTAL
Intervention: Subhepatic drains placed at the time of surgery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patients with subhepatic bile leakage
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bile leakage
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Modern interventional radiologic techniques
Number of subjects: 0
Study: 29508153

Group type: EXPERIMENTAL
Intervention: Ivabradine + Beta-Blockers
Number of subjects: 1104

Group type: COMPARATOR
Intervention: Beta-Blockers Uptitration
Number of subjects: 1104
Study: 27248464

Group type: EXPERIMENTAL
Intervention: SP loaded nanostructured lipid carrier gel (SP-NLC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SP loaded alcoholic gel (SP-ALC)
Number of subjects: 0
Study: 24957844

Group type: EXPERIMENTAL
Intervention: Teen Driving Plan (TDP)
Number of subjects: 217

Group type: COMPARATOR
Intervention: Control group (Pennsylvania driver's manual)
Number of subjects: 217
Study: 22617163

Group type: EXPERIMENTAL
Intervention: High-intensity resistance strength training and walking (E)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Individualized social activity (SA)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Resistance training and walking combined with social activity (ESA)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 119
Study: 20876410

Group type: EXPERIMENTAL
Intervention: Nearly hard stop alert intervention group
Number of subjects: 1981

Group type: COMPARATOR
Intervention: Standard practice control group
Number of subjects: 1981
Study: 18947267

Group type: EXPERIMENTAL
Intervention: Grandio Flow (GF)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: UniFil Flow (UF)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: UniFil LoFlo Plus (UL)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: DenFil Flow (DF)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Transbond XT (TX)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Filtek Z250 (FZ)
Number of subjects: 4
Study: 16841681

Group type: EXPERIMENTAL
Intervention: Acu-moxibustion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Randomized Control Trial (RCT)
Number of subjects: 0
Study: 14767171

Group type: EXPERIMENTAL
Intervention: High sucrose intake group
Number of subjects: 66

Group type: COMPARATOR
Intervention: Low sucrose intake group
Number of subjects: 66
Study: 11713152

Group type: EXPERIMENTAL
Intervention: Nasal oxygen delivery (52 patients)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Oral oxygen delivery (45 patients)
Number of subjects: 97
Study: 9336524

Group type: EXPERIMENTAL
Intervention: Surgical technique or extent of resection (exact details not provided)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study: 7898088

Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme (ACE) inhibitors
Number of subjects: 0

Group type: COMPARATOR
Intervention: High plasma renin activity
Number of subjects: 0

Group type: COMPARATOR
Intervention: ACE gene allele
Number of subjects: 0
Study: 2441201

Group type: COMPARATOR
Intervention: Hydralazine
Number of subjects: 15

Group type: COMPARATOR
Intervention: Captopril
Number of subjects: 15
Study: 30576164

Group type: EXPERIMENTAL
Intervention: Modulated spatially entangled photon pairs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Structured quantum illumination
Number of subjects: 0
Study: 26632432

Group type: EXPERIMENTAL
Intervention: Robots in low-level care lounges
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Robots in high-dependency care lounges
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lounges without robots (control)
Number of subjects: 0
Study: 24603565

Group type: COMPARATOR
Intervention: No prescription
Number of subjects: 889

Group type: EXPERIMENTAL
Intervention: Delayed prescription (recontact)
Number of subjects: 889

Group type: EXPERIMENTAL
Intervention: Delayed prescription (post‐dated)
Number of subjects: 889

Group type: EXPERIMENTAL
Intervention: Delayed prescription (collection)
Number of subjects: 889

Group type: EXPERIMENTAL
Intervention: Delayed prescription (patient led)
Number of subjects: 889

Group type: EXPERIMENTAL
Intervention: Immediate antibiotics
Number of subjects: 889
Study: 23759464

Group type: EXPERIMENTAL
Intervention: Assertive specialized treatment
Number of subjects: 547

Group type: COMPARATOR
Intervention: Standard treatment (Control)
Number of subjects: 547
Study: 21243757

Group type: EXPERIMENTAL
Intervention: L-carnitine (1 g bid for 3 months before PESA-ICSI)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control (untreated)
Number of subjects: 79
Study: 18440327

Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO) - single bolus of 60,000 IU administered within 3 hours of PCI
Number of subjects: 466

Group type: COMPARATOR
Intervention: Standard medical care
Number of subjects: 466
Study: 16832317

Group type: EXPERIMENTAL
Intervention: Methylphenidate (0.94 +/- 0.02 mg/kg/day = 33.06 +/- 1.40 mg/day)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41

Group type: COMPARATOR
Intervention: Unmedicated controls
Number of subjects: 41
Study: 12948399

Group type: EXPERIMENTAL
Intervention: Combination therapy with interferon alpha‐2b (3 MU tiw) and ribavirin (1000‐1200 mg/day)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Ribavirin monotherapy (1000‐1200 mg/day)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Ribavirin placebo
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Combination therapy with interferon and ribavirin
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Combination therapy with interferon ribavirin
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Ribavirin monotherapy
Number of subjects: 121
Study: 11049919

Group type: EXPERIMENTAL
Intervention: Low-flow sevoflurane anesthesia (1 L/min)
Number of subjects: 30

Group type: COMPARATOR
Intervention: High-flow sevoflurane anesthesia (6-10 L/min)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Low-flow isoflurane anesthesia (1 L/min)
Number of subjects: 30
Study: 8831399

Group type: EXPERIMENTAL
Intervention: 60 mg/day vesnarinone
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 30 mg/day vesnarinone
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 21
Study: 1530165

Group type: EXPERIMENTAL
Intervention: Thiopental alone (n = 17)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Thiopental with fentanyl (n = 18, fentanyl concentration 1.27 +/- 0.5 ng/mL)
Number of subjects: 46
Study: 3911613

Group type: EXPERIMENTAL
Intervention: Liquid dimeticon preparation (480 mg over 24 hours)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 31940468

Group type: EXPERIMENTAL
Intervention: FPIES triggered by 3 or more foods
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: FPIES triggered by cow's milk
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: FPIES triggered by banana
Number of subjects: 203
Study: 30201310

Group type: EXPERIMENTAL
Intervention: Coronary computed tomography angiography (CCTA)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Direct invasive coronary angiography (ICA)
Number of subjects: 120
Study: 26362826

Group type: EXPERIMENTAL
Intervention: Caucasian whortleberry (1 g/day) for 90 days
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Cinnamon (1 g/day) for 90 days
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study: 25168404

Group type: EXPERIMENTAL
Intervention: IV fluid (10 mL/kg IV 0.9% sodium chloride) with no expectation of medication (Group A)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: IV fluid (10 mL/kg IV 0.9% sodium chloride) with expectation of medication (Group B)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Follow-up data for patients
Number of subjects: 47

Group type: COMPARATOR
Intervention: Overall results
Number of subjects: 47
Study: 23257008

Group type: EXPERIMENTAL
Intervention: Tetrandrine tablets (100 mg bid) and matrine injection (150 mg qd)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group (anti-inflammatory, cough-relieving, and anti-asthmatic treatment only)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Tetrandrine tablets combined with matrine injection
Number of subjects: 63
Study: 19680660

Group type: EXPERIMENTAL
Intervention: Temporary double J ureteric stenting (TDJS) for 3 weeks
Number of subjects: 109

Group type: COMPARATOR
Intervention: Intervention in the form of pyeloplasty (24 patients) and endopyelotomy (38 patients) after TDJS
Number of subjects: 109
Study: 19000212

Group type: EXPERIMENTAL
Intervention: Trial-by-trial feedback in a repeated descriptive paradigm
Number of subjects: 0

Group type: COMPARATOR
Intervention: No feedback
Number of subjects: 0
Study: 15290195

Group type: EXPERIMENTAL
Intervention: Aspherical IOL
Number of subjects: 10

Group type: COMPARATOR
Intervention: Spherical IOL
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Both IOLs
Number of subjects: 10
Study: 12744879

Group type: EXPERIMENTAL
Intervention: ISS+20 microg HBsAg
Number of subjects: 48

Group type: COMPARATOR
Intervention: 20 microg HBsAg alone
Number of subjects: 48

Group type: COMPARATOR
Intervention: ISS alone
Number of subjects: 48
Study: 11783199

Group type: EXPERIMENTAL
Intervention: Step respiration exercise (SRE) combined with Chinese drug therapy (CDT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Chinese drug therapy (CDT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Step respiration exercise (SRE)
Number of subjects: 50
Study: 7860833

Group type: EXPERIMENTAL
Intervention: Signal detection model applied to Japanese listeners' /r/-/l/ labeling behavior
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Manipulation of subjects' response criteria
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Goodness of fit judgment
Number of subjects: 0
Study: 2045865

Group type: EXPERIMENTAL
Intervention: Recombinant human IL-3 (daily 4-hour intravenous infusion for 28 days at doses of 30, 60, 125, 250, 500, 750, and 1,000 micrograms/m2/d)
Number of subjects: 24
Study: 6941447

Group type: EXPERIMENTAL
Intervention: Single dose and two doses of intravenous metronidazole (500 mg/100 ml)
Number of subjects: 270

Group type: COMPARATOR
Intervention: Single dose of intravenous metronidazole (500 mg/100 ml) with placebo (100 ml normal saline)
Number of subjects: 270

Group type: COMPARATOR
Intervention: Placebo (100 ml normal saline) for both doses
Number of subjects: 270
Study: 31682535

Group type: EXPERIMENTAL
Intervention: Patients discharged to personal care homes
Number of subjects: 242
Study: 31261967

Group type: EXPERIMENTAL
Intervention: Total dietary fat intake (highest quintile)
Number of subjects: 6560

Group type: EXPERIMENTAL
Intervention: Monounsaturated fatty acids (MUFA) intake (highest quintile)
Number of subjects: 6560

Group type: EXPERIMENTAL
Intervention: Saturated fatty acids (SFA) intake (highest quintile)
Number of subjects: 6560

Group type: EXPERIMENTAL
Intervention: ω-3 fatty acids intake (highest quintile)
Number of subjects: 6560

Group type: EXPERIMENTAL
Intervention: Linoleic acid (LA) intake (highest quintile)
Number of subjects: 6560
Study: 27807291

Group type: EXPERIMENTAL
Intervention: Extracorporeal Shockwave Therapy (ESWT)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Radiofrequency Thermal Lesioning (RTL)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control Group (not specified)
Number of subjects: 56
Study: 25972574

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILI) for weight loss
Number of subjects: 1397

Group type: COMPARATOR
Intervention: Diabetes support and education (DSE)
Number of subjects: 1397
Study: 23857339

Group type: EXPERIMENTAL
Intervention: ≥30% improvement in abdominal pain (AP)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Global assessment of improvement
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Satisfaction with treatment
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Symptom relief
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: 30% change in FDI scores
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Abdominal pain improvement
Number of subjects: 72